ITGAX and neoplasm: A significant (p < 0.01) upregulation of the CD11c+CD80+CD86+ cell (matured DC) proportion in tumour draining lymph nodes was detected after US+CA treatment compared to untreated tumours (26.40 ± 3.70% vs. 13.03 ± 2.03%).